WGS on Nasdaq
GeneDx Holdings Corp.
American health services company, incorporated in Delaware.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with Sharecare, DocGo Inc. or Omada Health, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
69.7%Gross margin3
-3.1%Operating margin3
-4.9%Net margin3
40.0%Revenue growth, 20253
-6.8%Return on equity3
0.16×Debt to equity3
$14.3MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Diagnostic Test, Third Party Insurance brought in 81% of the revenue GeneDx Holdings Corp. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Diagnostic Test, Third Party Insurance | $134.5M | $234.7M | $345.2M |
| Diagnostic Test, Institutional Customers | $59.5M | $65.1M | $70.1M |
| Product and Service, Other | $6.9M | $3.3M | $10.9M |
| Diagnostic Test, Self Pay | $1.7M | $2.3M | $1.4M |
Business segments
GeneDx brought in 99% of the revenue GeneDx Holdings Corp. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| GeneDx | $194.4M | $302.3M | $423.1M |
| Other Operating | $8.2M | $3.2M | $4.5M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue30¢$129.4M
- Research and development17¢$72.0M
- Other costs53¢$226.0M
- Income tax0¢$116.0K
Out of $427.5M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending57¢$19.0M
- Kept or used elsewhere43¢$14.3M
Out of $33.3M of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total revenue | $427.5M | $305.4M | $202.6M |
| Cost of services | $129.4M | $111.1M | $112.6M |
| Gross profit | $298.2M | $194.4M | $90.0M |
| Research and development | $72.0M | $45.7M | $58.3M |
| Selling and marketing | $88.4M | $67.4M | $61.0M |
| General and administrative | $150.8M | $104.5M | $139.0M |
| Impairment loss | $0 | $0 | $10.4M |
| Other operating expenses, net | $0 | $0 | $2.0M |
| Loss from operations | -$13.1M | -$23.2M | -$180.6M |
| Change in fair value of financial liabilities | -$1.2M | -$13.4M | $1.2M |
| Interest (expense) income, net | -$2.5M | -$3.0M | $1.1M |
| Other (expense) income, net | -$4.3M | -$13.0M | $1.6M |
| Total non-operating (expense) income, net | -$8.1M | -$29.4M | $3.9M |
| Loss before income taxes | -$21.1M | -$52.6M | -$176.7M |
| Income tax benefit | $116.0K | $343.0K | $926.0K |
| Net loss | -$21.0M | -$52.3M | -$175.8M |
| Unrealized gain related to available for sale securities, net | $106.0K | $405.0K | $425.0K |
| Comprehensive loss | -$20.9M | -$51.9M | -$175.3M |
| Basic weighted average shares outstanding of Class A common stock (in shares) | 28.6M shares | 26.9M shares | 24.3M shares |
| Diluted weighted average shares outstanding of Class A common stock (in shares) | 28.6M shares | 26.9M shares | 24.3M shares |
| Basic net loss per share, Class A common stock (in dollars per share) | -$0.73 | -$1.94 | -$7.23 |
| Diluted net loss per share, Class A common stock (in dollars per share) | -$0.73 | -$1.94 | -$7.23 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $105.0M | $85.2M | ||
| Marketable securities | $66.3M | $56.0M | ||
| Accounts receivable | $74.4M | $37.6M | ||
| Inventory, net | $14.0M | $10.7M | ||
| Prepaid expenses and other current assets | $8.7M | $8.5M | ||
| Total current assets | $268.3M | $198.0M | ||
| Operating lease right-of-use assets | $23.4M | $25.6M | ||
| Property and equipment, net | $45.7M | $32.9M | ||
| Goodwill | $13.5M | $0 | ||
| Intangible assets, net | $168.5M | $158.6M | ||
| Other assets | $4.3M | $4.3M | ||
| Total assets | $523.7M | $419.4M | ||
| Accounts payable and accrued expenses | $57.6M | $31.0M | ||
| Short-term lease liabilities | $4.4M | $3.3M | ||
| Other current liabilities | $46.9M | $20.5M | ||
| Total current liabilities | $108.9M | $54.8M | ||
| Long-term debt, net of current portion | $48.2M | $51.9M | ||
| Long-term lease liabilities | $56.0M | $60.9M | ||
| Other liabilities | $1.6M | $5.5M | ||
| Deferred taxes | $757.0K | $965.0K | ||
| Total liabilities | $215.5M | $174.1M | ||
| Preferred Stock, $0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $0 | $0 | ||
| Class A common stock, $0.0001 par value: 1,000,000,000 shares authorized, 29,245,296 and 28,016,545 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $3.0K | $2.0K | ||
| Additional paid-in capital | $1.7B | $1.6B | ||
| Accumulated deficit | -$1.4B | -$1.4B | ||
| Accumulated other comprehensive income | $936.0K | $830.0K | ||
| Total stockholders equity | $308.2M | $245.2M | $228.0M | $253.7M |
| Total liabilities and stockholders equity | $523.7M | $419.4M | ||
| Preferred stock par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 1.0M shares | 1.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, authorized (in shares) | 1.0B shares | 1.0B shares | ||
| Common stock, issued (in shares) | 29.2M shares | 28.0M shares | ||
| Common stock, outstanding (in shares) | 29.2M shares | 28.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $105.0M | $85.2M | ||
| Marketable securities | $66.3M | $56.0M | ||
| Accounts receivable | $74.4M | $37.6M | ||
| Inventory, net | $14.0M | $10.7M | ||
| Prepaid expenses and other current assets | $8.7M | $8.5M | ||
| Total current assets | $268.3M | $198.0M | ||
| Operating lease right-of-use assets | $23.4M | $25.6M | ||
| Property and equipment, net | $45.7M | $32.9M | ||
| Goodwill | $13.5M | $0 | ||
| Intangible assets, net | $168.5M | $158.6M | ||
| Other assets | $4.3M | $4.3M | ||
| Total assets | $523.7M | $419.4M | ||
| Accounts payable and accrued expenses | $57.6M | $31.0M | ||
| Short-term lease liabilities | $4.4M | $3.3M | ||
| Other current liabilities | $46.9M | $20.5M | ||
| Total current liabilities | $108.9M | $54.8M | ||
| Long-term debt, net of current portion | $48.2M | $51.9M | ||
| Long-term lease liabilities | $56.0M | $60.9M | ||
| Other liabilities | $1.6M | $5.5M | ||
| Deferred taxes | $757.0K | $965.0K | ||
| Total liabilities | $215.5M | $174.1M | ||
| Preferred Stock, $0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $0 | $0 | ||
| Class A common stock, $0.0001 par value: 1,000,000,000 shares authorized, 29,245,296 and 28,016,545 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $3.0K | $2.0K | ||
| Additional paid-in capital | $1.7B | $1.6B | ||
| Accumulated deficit | -$1.4B | -$1.4B | ||
| Accumulated other comprehensive income | $936.0K | $830.0K | ||
| Total stockholders equity | $308.2M | $245.2M | $228.0M | $253.7M |
| Total liabilities and stockholders equity | $523.7M | $419.4M | ||
| Preferred stock par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 1.0M shares | 1.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, authorized (in shares) | 1.0B shares | 1.0B shares | ||
| Common stock, issued (in shares) | 29.2M shares | 28.0M shares | ||
| Common stock, outstanding (in shares) | 29.2M shares | 28.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$21.0M | -$52.3M | -$175.8M |
| Depreciation and amortization expense | $25.2M | $22.0M | $33.7M |
| Stock-based compensation expense | $32.2M | $9.1M | -$326.0K |
| Change in fair value of financial liabilities | $1.2M | $13.4M | -$1.2M |
| Provision for excess and obsolete inventory | $135.0K | $180.0K | $3.9M |
| Legal reserves | $5.6M | $0 | $0 |
| Change in third party payor reserves | $2.4M | $607.0K | -$9.7M |
| Impairment loss | $0 | $0 | $10.4M |
| Other | $3.2M | $3.3M | -$2.9M |
| Accounts receivable | -$36.2M | -$5.2M | $10.5M |
| Inventory | -$3.4M | -$2.6M | $975.0K |
| Accounts payable and accrued expenses | $12.1M | -$20.5M | -$49.2M |
| Other assets and liabilities | $12.0M | $3.5M | -$575.0K |
| Net cash provided by (used in) operating activities | $33.3M | -$28.5M | -$180.1M |
| Purchases of marketable securities | -$55.7M | -$66.3M | -$47.7M |
| Proceeds from sales of marketable securities | $2.1M | $601.0K | $0 |
| Proceeds from maturities of marketable securities | $44.0M | $41.1M | $17.8M |
| Purchases of property and equipment | -$19.0M | -$5.5M | -$5.2M |
| Proceeds from sales of assets | $0 | $0 | $4.0M |
| Development of internal-use software assets | $0 | $0 | -$461.0K |
| Net cash used in investing activities | -$61.5M | -$30.1M | -$43.7M |
| Proceeds from offerings, net of issuance costs | $46.7M | $46.5M | $143.0M |
| Proceeds from issuance of stock pursuant to employee stock purchase plan | $3.0M | $497.0K | $0 |
| Exercise of stock options | $2.0M | $394.0K | $285.0K |
| Long-term debt principal payments | -$1.2M | -$497.0K | -$2.0M |
| Finance lease payoff and principal payments | -$2.5M | -$2.7M | -$3.6M |
| Proceeds from long-term debt | $0 | $0 | $48.5M |
| Net cash provided by financing activities | $48.0M | $44.2M | $186.2M |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $19.8M | -$14.5M | -$37.6M |
| Cash paid for interest | $6.4M | $6.7M | $3.0M |
| Cash paid for taxes | $1.3M | $1.2M | $1.5M |
| Purchases of property and equipment in accounts payable and accrued expenses | $6.3M | $2.6M | $134.0K |
| Stock consideration paid pursuant to exercise of Perceptive warrant | $0 | $12.6M | $0 |
| Assets acquired under capital leases obligations | $0 | $689.0K | $0 |
| Issuance of common stock for first OPKO Milestone Payment | $0 | $0 | $6.7M |
| Lease liability from obtaining right-of-use asset | $0 | $0 | $637.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led GeneDx Holdings Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
Chief operating officer
2025
- Chief executive officerKatherine Stueland May 2, 2022 to now10
- Chief executive officerEric Schadt Jul 22, 2021 to Apr 27, 202211
- Chief executive officerEli Casdin Sep 1, 2020 to Sep 1, 202012
- ChairJason Ryan Oct 18, 2022 to Jan 3, 202413
- PresidentMark A. Gardner Jun 16, 2026 to now14
- PresidentEric Schadt May 2, 2022 to May 24, 202215
- PresidentJames Coffin Jul 22, 2021 to Dec 13, 202116
- Chief financial officerRichard Miao Jun 23, 2022 to Jun 23, 202217
- Chief financial officerKevin Feeley Sep 2, 2022 to now18
- Chief financial officerIsaac Ro Jul 22, 2021 to May 31, 202319
- Chief financial officerBrian Emes Sep 1, 2020 to Sep 1, 202020
- Chief operating officerBryan Dechairo Jan 13, 2025 to now21
- Chief operating officerJames Coffin Jul 22, 2021 to Dec 13, 202116
Board members and other officers (19)
- Chief Product OfficerAnthony Prentice Jul 22, 2021 to Jul 27, 202222
- Chief Business OfficerKareem Saad Jul 22, 2021 to Mar 19, 202423
- Chief People OfficerKaren Ann White Jul 22, 2021 to Jul 27, 202324
- Chief Accounting OfficerShawn Assad Jul 22, 2021 to May 12, 202225
- Chief Strategy OfficerShaun Rodriguez Sep 1, 2020 to Sep 1, 202026
- Board memberThomas Fuchs Sep 19, 2025 to now27
- Board memberKatherine Stueland May 2, 2022 to now10
- Board memberRichard C. Pfenniger Jr. May 2, 2022 to now28
- Board memberDennis Charney Jul 22, 2021 to Oct 19, 202129
- Board memberEric Schadt Jul 22, 2021 to May 24, 202211
- Board memberJason Ryan Jul 22, 2021 to now30
- Board memberJoshua Ruch Jul 22, 2021 to now31
- Board memberMichael J. Pellini Jul 22, 2021 to Oct 18, 202232
- Board memberRachel E. Sherman Jul 22, 2021 to May 4, 202333
- Board memberEli Casdin Sep 1, 2020 to now12
- Board memberEmily Leproust Sep 1, 2020 to now34
- Board memberMunib Islam Sep 1, 2020 to Sep 1, 202035
- Board memberNat Turner Sep 1, 2020 to May 12, 202236
- Board memberSean E. George Sep 1, 2020 to Sep 1, 202037
Former names
Timeline
Filings
677 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 55 major events, 407 insider forms, 49 large holders, 146 other. The latest 20:
- Sep 18, 20264 EDGAR
- Sep 18, 20264 EDGAR
- Sep 18, 20264 EDGAR
- Sep 11, 20264 EDGAR
- Sep 11, 20264 EDGAR
- Sep 3, 20264 EDGAR
- Sep 1, 2026144 EDGAR
- Sep 1, 2026144 EDGAR
- Aug 11, 2026SCHEDULE 13G EDGAR
- Aug 7, 2026SCHEDULE 13G/A EDGAR
- Aug 3, 202610-Q EDGAR
- Aug 3, 20268-K EDGAR
- Jul 28, 2026SCHEDULE 13G EDGAR
- Jul 21, 202625-NSE EDGAR
- Jul 1, 20264 EDGAR
- Jun 23, 20264 EDGAR
- Jun 23, 20264 EDGAR
- Jun 23, 20268-K EDGAR
- Jun 23, 20264 EDGAR
- Jun 23, 20264 EDGAR
The 677 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 49 such filings since October 2021, the latest 10:
- Aug 11, 2026SCHEDULE 13G
- Aug 7, 2026SCHEDULE 13G/A
- Jul 28, 2026SCHEDULE 13G
- May 22, 2026SCHEDULE 13D/A
- May 15, 2026SCHEDULE 13D/A
- May 11, 2026SCHEDULE 13D/A
- Nov 12, 2025SCHEDULE 13G/A
- Aug 26, 2025SCHEDULE 13D/A
- Aug 14, 2025SCHEDULE 13G/A
- Aug 6, 2025SCHEDULE 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Corvex Management LP | 4,784,570 | $328.5M | 10.2% | +1,556,421 |
| Casdin Capital, LLC | 3,707,164 | $254.5M | 12.7% | +700,000 |
| BlackRock, Inc. | 1,706,239 | $117.1M | 0.0% | +155,531 |
| Goldman Sachs Group Inc | 1,669,441 | $114.6M | 0.0% | +334,461 |
| ARK Investment Management LLC | 1,610,189 | $110.5M | 0.7% | +285,606 |
| William Blair Investment Management, LLC | 1,400,653 | $96.2M | 0.3% | +625,384 |
| Morgan Stanley | 988,297 | $67.8M | 0.0% | +456,062 |
| Vanguard Capital Management LLC | 879,003 | $60.3M | 0.0% | +20,420 |
| Citadel Advisors LLC | 865,462 | $59.4M | 0.0% | +218,061 |
| First Light Asset Management, LLC | 783,923 | $53.8M | 3.3% | +540,996 |
| Deep Track Capital, LP | 700,000 | $48.1M | 0.7% | New |
| Sumitomo Mitsui Trust Group, Inc. | 666,581 | $45.8M | 0.0% | +33,124 |
| Amova Asset Management Americas, Inc. | 666,581 | $45.7M | 0.6% | +27,781 |
| Assenagon Asset Management S.A. | 606,866 | $41.7M | 0.0% | +511,738 |
| Zweig-DiMenna Associates LLC | 571,950 | $39.3M | 3.6% | −117,340 |
| Geode Capital Management, LLC | 552,125 | $37.9M | 0.0% | +2,978 |
| State Street Corp | 527,815 | $36.2M | 0.0% | +55,370 |
| Gagnon Securities LLC | 524,865 | $36.0M | 6.9% | +221,716 |
| Aberdeen Group plc | 457,201 | $31.4M | 0.0% | +227,105 |
| Wellington Management Group Llp | 347,927 | $23.9M | 0.0% | +6,922 |
| Bank Of America Corp /de/ | 346,211 | $23.8M | 0.0% | +111,605 |
| Franklin Resources Inc | 280,938 | $19.3M | 0.0% | −326,283 |
| Dimensional Fund Advisors LP | 280,619 | $19.3M | 0.0% | +14,828 |
| Norges Bank | 273,100 | $18.7M | 0.0% | New |
| Eventide Asset Management, LLC | 269,542 | $18.5M | 0.2% | −189,473 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGAREric Schadt, Chief executive officer
- 12SEC EDGAREli Casdin, Chief executive officer
- 13SEC EDGARJason Ryan, Chair
- 14SEC EDGARMark A. Gardner, President
- 15SEC EDGAREric Schadt, President
- 16SEC EDGARJames Coffin, President
- 17
- 18
- 19SEC EDGARIsaac Ro, Chief financial officer
- 20SEC EDGARBrian Emes, Chief financial officer
- 21
- 22
- 23SEC EDGARKareem Saad, Chief Business Officer
- 24
- 25
- 26
- 27SEC EDGARThomas Fuchs, Board member
- 28
- 29SEC EDGARDennis Charney, Board member
- 30SEC EDGARJason Ryan, Board member
- 31SEC EDGARJoshua Ruch, Board member
- 32SEC EDGARMichael J. Pellini, Board member
- 33SEC EDGARRachel E. Sherman, Board member
- 34SEC EDGAREmily Leproust, Board member
- 35SEC EDGARMunib Islam, Board member
- 36SEC EDGARNat Turner, Board member
- 37SEC EDGARSean E. George, Board member